跳至主要内容
临床试验/JPRN-UMIN000043671
JPRN-UMIN000043671招募中未知

Observational study on efficacy and safety of vaccines against the novel coronavirus disease (COVID-19) in hematopoietic stem cell transplantation (HSCT) patient. - FBMTG-COVID-19-VAC

Fukuoka Blood and Marrow Transplantation Group0 个研究点目标入组 1,000 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Grade III-IV acute GVHD at the time of registration. 2.Anti-CD20 antibody therapy within 6 months. 3.CAR-T cell therapy within 6 months with B cell depletion. 4.Anti-thymocyte globulin (ATG) or alemtuzumab therapy within 6 months. 5.Judged to be inappropriate by the principal investigator and the research coordinator.

研究者

发起方
Fukuoka Blood and Marrow Transplantation Group

相似试验